Effectiveness of nifedipine compared with other antihypertension
Por um escritor misterioso
Descrição
Nifedipine has better effectiveness in lowering blood pressure compared to other antihypertensives such as IV labetalol, oral labet alol, IV hydralazine, methyldopa in the treatment of preeclampsia, severe preeclamping, severe pre-eclampsian, chronic hypertension, hypertension emergency, and severe hypertension. Hypertension is the most common complication of pregnancy. It is a major cause of maternal, fetal, and neonatal morbidity and mortality. In this article, the effectiveness of nifedipine compared with other antihypertensives in pregnant women with hypertension was reviewed. The randomized control trial (RCT) of nifedipine and other antihypertension in pregnancy without complications published from 2016 to 2021 in Google Scholar, Cochrane and PubMed were gathered. It was reported that antihypertensives administration to pregnant women with hypertension was very meaningful both for the mother herself and for the fetus or baby. Furthermore, nifedipine has better effectiveness in lowering blood pressure compared to other antihypertensives such as IV labetalol, oral labetalol, IV hydralazine, methyldopa in the treatment of preeclampsia, severe preeclampsia, severe pre-eclampsia/eclampsia, chronic hypertension, hypertension emergency, and severe hypertension.
PDF) Efficacy of Nifedipine versus Hydralazine in the Management
Safety of Nifedipine in Patients With Hypertension
Best Practices for Managing Postpartum Hypertension
JCDD, Free Full-Text
Effectiveness of nifedipine compared with other antihypertension
Norvasc® Efficacy
Nifedipine gastrointestinal therapeutic system (GITS): a guide to
Hydralazine vs nifedipine for acute hypertensive emergency in
Oral antihypertensive regimens (nifedipine retard, labetalol, and
Nifedipine Extended-Release Tablets: PI
Trends in the market for antihypertensive drugs
Nifedipine in pregnancy - Aedla - 2012 - Practical Diabetes
Full article: Comparison of ambulatory blood pressure-lowering
Morbidity and mortality in patients randomised to double-blind
de
por adulto (o preço varia de acordo com o tamanho do grupo)